Funding · Company
Atsena Therapeutics, Inc.
Durham, NCBiotech & Pharma
Atsena Therapeutics, Inc. of Durham, NC has disclosed $114M across 2 Form D offerings filed with the SEC between Oct 2, 2023 and Apr 11, 2025.
$114M
Total disclosed
2
Form D offerings
2019
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$90M
Form D · Apr 11, 2025 ↗
Q2 2025
· target $150M
$24M
Form D · Oct 2, 2023 ↗
Q4 2023
· target $32M
Filing details
HeadquartersDurham, NCIndustryBiotech & Pharma (Biotechnology)Incorporated2019SEC CIK0001811468Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →